Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MAPP

Harbor Multi asset Explo... (MAPP)

Harbor Multi asset Explorer ETF

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:MAPP

Date	Time	Source	Headline	Symbol	Company
16/02/2010	23:00	PR Newswire (US)	MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics Trial	NYSE:MAPP
06/01/2010	23:00	PR Newswire (US)	MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference	NYSE:MAPP
12/11/2009	23:00	PR Newswire (US)	MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility	NYSE:MAPP
11/11/2009	23:00	PR Newswire (US)	MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference	NYSE:MAPP
29/10/2009	22:00	PR Newswire (US)	MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients	NYSE:MAPP
10/09/2009	21:00	PR Newswire (US)	MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of	NYSE:MAPP
02/09/2009	21:00	PR Newswire (US)	MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences	NYSE:MAPP
09/07/2009	23:40	Dow Jones News	AstraZeneca Terminates MAP Pharma Pact, Sees $44 Million charge In 2Q	NYSE:MAPP	MAP Pharmaceuticals Inc.
09/07/2009	22:30	PR Newswire (US)	MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration	NYSE:MAPP
05/10/2007	23:00	PR Newswire (US)	MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering	NYSE:MAPP